Changeflow GovPing Pharma & Drug Safety Patent Publication EP2023205892A1: CDK Inhibito...
Routine Notice Added Final

Patent Publication EP2023205892A1: CDK Inhibitors and Pharmaceutical Uses

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Organic Chemistry (C07D)
Published March 11th, 2026
Detected March 26th, 2026
Email

Summary

The European Patent Office has published patent application EP2023205892A1 concerning CDK inhibitors and their pharmaceutical uses, filed by Risen (Suzhou) Pharma Tech Co., Ltd. This publication provides details on the chemical compounds and their potential applications in treating diseases.

What changed

This document is a patent publication (EP2023205892A1) from the European Patent Office detailing chemical compounds classified under C07D and their pharmaceutical applications, specifically related to CDK inhibitors. The applicant is Risen (Suzhou) Pharma Tech Co., Ltd. The publication date is March 11, 2026.

This is a patent publication, not a regulatory rule or guidance. Therefore, there are no direct compliance obligations or deadlines for regulated entities. Companies involved in pharmaceutical research and development, particularly in oncology, should note this publication for potential intellectual property landscape analysis and competitive intelligence.

Source document (simplified)

← EPO Patent Bulletin

CDK INHIBITORS AND PHARMACEUTICAL USES THEREOF

Publication EP2023205892A1 Kind: A1 Mar 11, 2026

Applicants

Risen (Suzhou) Pharma Tech Co., Ltd.

Inventors

The designation of the inventor has not yet been filed

IPC Classifications

C07D 413/14 20060101AFI20231103BHEP A61K 9/00 20060101ALI20231103BHEP A61K 47/50 20170101ALI20231103BHEP A61K 47/54 20170101ALI20231103BHEP A61P 35/00 20060101ALI20231103BHEP C07D 401/14 20060101ALI20231103BHEP C07D 403/04 20060101ALI20231103BHEP C07D 409/14 20060101ALI20231103BHEP C07D 471/04 20060101ALI20231103BHEP C07D 471/10 20060101ALI20231103BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Classification

Agency
EPO
Published
March 11th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP2023205892A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Drug Development Intellectual Property
Geographic scope
European Union EU

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Compliance frameworks
FDA 21 CFR Part 11
Topics
Intellectual Property Drug Development

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Organic Chemistry (C07D) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.